These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21554048)

  • 1. Therapy for metastatic melanoma: an overview and update.
    Boyle GM
    Expert Rev Anticancer Ther; 2011 May; 11(5):725-37. PubMed ID: 21554048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistance.
    Koon HB; Atkins MB
    Expert Rev Anticancer Ther; 2007 Jan; 7(1):79-88. PubMed ID: 17187522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma: from darkness to promise.
    Gasent Blesa JM; Grande Pulido E; Alberola Candel V; Provencio Pulla M
    Am J Clin Oncol; 2011 Apr; 34(2):179-87. PubMed ID: 20498590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
    Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
    Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for metastatic malignant melanoma: old drugs and new strategies.
    Mouawad R; Sebert M; Michels J; Bloch J; Spano JP; Khayat D
    Crit Rev Oncol Hematol; 2010 Apr; 74(1):27-39. PubMed ID: 19781957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant melanoma--future prospects.
    Lugović L; Situm M; Kos L
    Acta Dermatovenerol Croat; 2005; 13(1):36-43. PubMed ID: 15788145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual fronts poised to transform melanoma therapy.
    Mullard A
    Nat Rev Drug Discov; 2011 May; 10(5):325-6. PubMed ID: 21532549
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunology and immunotherapy of human malignant melanoma.
    Bystryn JC
    Dermatol Clin; 1985 Apr; 3(2):327-34. PubMed ID: 2937585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current therapy for malignant melanoma.
    Legha SS
    Semin Oncol; 1989 Feb; 16(1 Suppl 1):34-44. PubMed ID: 2465575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New therapeutical strategies in the treatment of metastatic disease.
    Julia F; Thomas L; Dalle S
    Dermatol Ther; 2012; 25(5):452-7. PubMed ID: 23046024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of advanced or metastatic melanoma.
    Cebon J; Gedye C; John T; Davis ID
    Clin Adv Hematol Oncol; 2007 Dec; 5(12):994-1006. PubMed ID: 18277962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant and palliative therapy of melanoma. Current status].
    Tilgen W
    Chirurg; 1994 Mar; 65(3):153-63. PubMed ID: 7514966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape.
    Zigler M; Villares GJ; Lev DC; Melnikova VO; Bar-Eli M
    Am J Clin Dermatol; 2008; 9(5):307-11. PubMed ID: 18717605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for advanced melanoma: fulfilling the promise.
    Gogas H; Polyzos A; Kirkwood J
    Cancer Treat Rev; 2013 Dec; 39(8):879-85. PubMed ID: 23725878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
    Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
    Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
    Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-based therapy for melanoma: pre-clinical studies.
    Shurin MR; Kirkwood JM; Esche C
    Forum (Genova); 2000; 10(3):204-26. PubMed ID: 11007930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma.
    Kirkwood JM; Mascari RA; Edington HD; Rabkin MS; Day RS; Whiteside TL; Vlock DR; Shipe-Spotloe JM
    Cancer; 2000 Jun; 88(12):2693-702. PubMed ID: 10870051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal hybridoma antibodies in human melanoma: current status.
    Burk MW
    Int Adv Surg Oncol; 1984; 7():241-70. PubMed ID: 6205999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.